Drug Patents owned by Benuvia
1. Drug name - SYNDROS
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9345771 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) | |
| US8222292 | BENUVIA | Liquid cannabinoid formulations |
Aug, 2028
(5 years from now) | |
| US10265293 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) | |
| US11253472 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 5MG/ML | SOLUTION;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.